Goldman Sachs Initiates Coverage On Organon with Neutral Rating, Announces Price Target of $35
Today, 10:53 AM
Goldman Sachs analyst Terence Flynn initiates coverage on Organon (NYSE:OGNW) with a Neutral rating and announces Price Target of $35.